P. Chanez

发表

Nitrogen washout slope in poorly controlled asthma

C. Prefaut, P. Godard, A. Bourdin, 2005, Allergy.

Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations

C. Delacourt, M. Humbert, P. Devillier, 2007, Allergy.

Adherence in severe asthma

I. Vachier, P. Godard, A. Bourdin, 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Relation between inflammation and symptoms in asthma

M. Humbert, N. Roche, I. Tillie‐Leblond, 2009, Allergy.

Near‐fatal asthma phenotype in the ENFUMOSA Cohort

A. Vignola, N. Siafakas, A. Papi, 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6

J. Vernejoux, R. Marthan, P. Berger, 2010, Allergy.

Contribution of exhaled nitric oxide measurement in airway inflammation assessment in asthma. A position paper from the French Speaking Respiratory Society.

I. Annesi-Maesano, A. Didier, N. Roche, 2015, Revue des maladies respiratoires.

[Asthma exacerbations: what are the issues?].

A. Magnan, G. Garcia, P. Chanez, 2011, Revue des maladies respiratoires.

How should nasal symptoms be investigated in asthma? A comparison of radiologic and endoscopic findings

J. Klossek, A. Didier, J. Tunon-de-lara, 2004, Allergy.

Prevalence and management of chronic breathlessness in COPD in a tertiary care center

D. Caillaud, C. Morélot-Panzini, N. Roche, 2019, BMC Pulmonary Medicine.

[The relationship between inflammation and symptoms in asthma].

M. Humbert, N. Roche, I. Tillie‐Leblond, 2008, Revue des maladies respiratoires.

Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

O. Kalayci, I. Agache, P. Hellings, 2019, Allergy.

Online supplement methods and figures Human bronchial epithelium orchestrates dendritic cell activation in severe asthma. D.Gras

I. Vachier, D. Gras, J. Vitte, 2017 .

Comparison of anti‐interleukin‐5 therapies in patients with severe asthma: global and indirect meta‐analyses of randomized placebo‐controlled trials

I. Vachier, N. Molinari, A. Bourdin, 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma

E. Nizankowska-Mogilnicka, S. Dahlén, S. Holgate, 2014, Allergy.

Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de pneumologie de langue française (SPLF) (summary).

I. Tillie‐Leblond, G. Deslée, J. Dubus, 2016, Revue des maladies respiratoires.

Frequent exacerbators – a distinct phenotype of severe asthma

E. Nizankowska-Mogilnicka, S. Dahlén, B. Dahlén, 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[Adult asthma exacerbations in questions].

M. Humbert, I. Tillie‐Leblond, L. Bertoletti, 2010, Revue des maladies respiratoires.

Clinical and economic burden of severe asthma: A French cohort study.

M. Humbert, T. Similowski, N. Roche, 2018, Respiratory medicine.

Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics

A Magnan, I Vachier, M. Humbert, 2009, Allergy.

Updated guidelines (2015) for management and monitoring of adult and adolescent asthmatic patients (from 12 years and older) of the Société de Pneumologie de Langue Française (SPLF) (Full length text).

I. Tillie‐Leblond, G. Deslée, J. Dubus, 2016, Revue des maladies respiratoires.

Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort

M. Elsensohn, J. Piette, R. Roussel, 2016, Orphanet Journal of Rare Diseases.